Anson Funds Management LP 13D/13G Filings for Hepion Pharmaceuticals, Inc. (HEPA)

Anson Funds Management LP 13D and 13G filings for Hepion Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-05-15
5:23 pm
Purchase
2025-03-31 13G Hepion Pharmaceuticals, Inc.
HEPA
Anson Funds Management LP 595,719
9.900%
595,538increase
(+328311.63%)
Filing